AMIAS

This brand name is authorized in United Kingdom

Active ingredients

The drug AMIAS contains one active pharmaceutical ingredient (API):

1 Candesartan UNII S8Q36MD2XX - CANDESARTAN

Candesartan is an AIIRA, selective for AT1 receptors, with tight binding to and slow dissociation from the receptor. It has no agonist activity. The antagonism of the angiotensin II (AT1) receptors results in dose related increases in plasma renin levels, angiotensin I and angiotensin II levels, and a decrease in plasma aldosterone concentration. Read about Candesartan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AMIAS Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09CA06	Candesartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13439, 13515, 13516, 13518, 13519, 198645, 198648, 198650, 299597, 299599, 89840